Division of Cardiovascular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts.
Division of Cardiovascular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts; DeBakey Heart & Vascular Center, Houston Methodist Hospital, Houston, TX.
Am J Cardiol. 2021 Feb 1;140:1-6. doi: 10.1016/j.amjcard.2020.10.054. Epub 2020 Nov 6.
Whether very young patients (≤35-year-old) differ in the prevalence, presentation and prognosis of ACS is not well known. Of 43,446 patients who were referred to a tertiary care cardiac catheterization laboratory between January 1, 2006 and June 30, 2017, 26,545 patients were ACS (defined as ST Elevation MI, Non-ST Elevation MI or unstable angina pectoris). Detailed chart review was performed and characteristics at baseline were compared for ages ≤35 years, ages 36 to 54 years and ages ≥55 years. A total of 291 (1.1%) were ≤35-year-old, 7,649 (28.8) were 36 to 54-year-old and 18,605 (70.1%) were ≥55-year-old. ACS patients aged ≤35-year-old, were more likely to be men, Caucasian white, smoker, obese, and have family history of coronary artery disease and less likely to have comorbidities such as hypertension, diabetes mellitus, and hyperlipidemia compared with older patients. They were also more likely to present with elevated troponin levels than other groups. They also tended to present with late ST elevation myocardial infarction and were more likely to receive bare metal stents than older patients. The prevalence of 2- and 3-vessel disease was lower compared with older patients. They also had higher prevalence of cardiogenic shock. Compared with 36 to 54-year-old patients, ≤35-year-old were at significant higher risk of 30-day mortality in a multivariable adjusted regression model (Odds ratio 5.65, 95% confidence interval 2.49 to 12.82, p <0.001). Very young patients comprised ∼1% of all ACS cases but had much more prevalence of modifiable risk factors and significantly worse mortality. Modifying these risk factors may mitigate the risk in these patients and should be studied in the future.
在 ACS 的患病率、表现和预后方面,非常年轻的患者(≤35 岁)是否存在差异尚不清楚。在 2006 年 1 月 1 日至 2017 年 6 月 30 日期间,有 43446 名患者被转诊至三级心脏导管实验室,其中 26545 名患者被诊断为 ACS(定义为 ST 段抬高型心肌梗死、非 ST 段抬高型心肌梗死或不稳定型心绞痛)。对详细的病历进行了回顾,比较了年龄≤35 岁、年龄 36-54 岁和年龄≥55 岁的患者的基线特征。共有 291 名(1.1%)患者年龄≤35 岁,7649 名(28.8%)患者年龄 36-54 岁,18605 名(70.1%)患者年龄≥55 岁。与年龄较大的患者相比,年龄≤35 岁的 ACS 患者更有可能是男性、白种人、吸烟者、肥胖者,并且有家族性冠心病史,合并症如高血压、糖尿病和高脂血症的发生率较低。与其他组相比,他们的肌钙蛋白水平升高的可能性也更高。他们也更倾向于出现晚期 ST 段抬高型心肌梗死,并且比年龄较大的患者更有可能接受金属裸支架治疗。与年龄较大的患者相比,2 支和 3 支血管病变的发生率较低。他们也有更高的心源性休克发生率。与 36-54 岁的患者相比,≤35 岁的患者在多变量调整后的回归模型中,30 天死亡率的风险显著更高(比值比 5.65,95%置信区间 2.49 至 12.82,p<0.001)。非常年轻的患者占所有 ACS 病例的 1%左右,但具有更多的可改变的危险因素,且死亡率明显更高。改变这些危险因素可能会降低这些患者的风险,应在未来进行研究。